Science
Mechanism of Action
RETINOYL OLIGOPEPTIDE-86 operates through a dual-action pathway. The retinoid component, upon epidermal conversion to retinoic acid, actively stimulates cellular growth and differentiation, thereby mitigating wrinkles, diminishing dark spots, and refining fine lines. It also modulates melanin synthesis by inhibiting tyrosinase and normalizes follicular activity to prevent pore clogging and acne. Concurrently, the oligopeptide segment functions as a potent skin-conditioning agent, initiating endogenous repair mechanisms that accelerate epidermal cell growth, proliferation, and differentiation, visibly improving skin texture, reducing pore size, and addressing dyschromatic conditions.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 While direct clinical data for RETINOYL OLIGOPEPTIDE-86 is not available, studies on related technologies provide significant insight. RetinSphere® Technology, utilizing stable retinoids like hydroxypinacolone retinoate and encapsulated retinol, has demonstrated efficacy in addressing acne, dark spots, and mature skin concerns.
- 02 Research indicates that a 0.3% retinol formulation can achieve similar dermal and epidermal remodeling benefits as a 1% formulation, with improved tolerability.
- 03 Further studies utilizing lipid nanocarriers for retinol and a related oligopeptide (pentapeptide-18) showed promise in reducing sebum secretion and facial wrinkles at minimized concentrations.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
The retinoid component is susceptible to oxidative and photo-induced degradation, with acidic conditions promoting dimerization. Oligopeptides are pH-sensitive and vulnerable to enzymatic decomposition by microorganisms. Formulation strategies to enhance stability and controlled release include the use of antioxidants, protective packaging (impermeable to gases, UV, and visible light), and advanced microparticle delivery systems such as lipid nanocarriers.
Synergies
- Antioxidants (for retinoid stability)
- Encapsulation technologies (e.g., lipid nanocarriers for improved stability and controlled release)
- Protective packaging (impermeable to gases, UV, and visible light)
Conflicts
- Acids at low pH (compromises retinoid stability)
- Microbial contamination (leads to oligopeptide decomposition)
Safety
Safety Profile
No explicit safety assessments by CIR, SCCS, or FDA for RETINOYL OLIGOPEPTIDE-86 have been found. Context from related ingredients suggests that while retinol and retinyl palmitate are considered safe for cosmetic use, potential systemic absorption remains an area of inquiry. For oligopeptides, the CIR Panel has previously sought more detailed amino acid sequence information, citing concerns about certain small peptides potentially stimulating angiogenesis or tumor growth in cases of undiagnosed skin cancer. This highlights the need for specific, comprehensive safety evaluations for novel peptide conjugates like RETINOYL OLIGOPEPTIDE-86.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to the absence of specific clinical and safety data for RETINOYL OLIGOPEPTIDE-86 itself, its overall rating remains 'insufficient-data', despite the well-established benefits of its individual retinoid and oligopeptide components for advanced skin renewal and anti-aging.
Related
Similar Ingredients
Finding similar ingredients…